Title : Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.

Pub. Date : 2015 Nov

PMID : 26493064






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Women with poor prognostic features of low PgR and/or high Ki-67 have greater absolute benefit from exemestane + OFS versus tamoxifen + OFS or tamoxifen alone, but individually PgR and Ki-67 are of limited predictive value for selecting adjuvant endocrine therapy for premenopausal women with HR+/HER2- early breast cancer. exemestane erb-b2 receptor tyrosine kinase 2 Homo sapiens